Builders FirstSource Inc. logo

Builders FirstSource Inc. (BLDR)

Market Closed
5 Dec, 20:00
NYSE NYSE
$
110. 01
-1
-0.9%
$
12.36B Market Cap
14.21 P/E Ratio
0% Div Yield
1,854,295 Volume
13.69 Eps
$ 111.01
Previous Close
Day Range
109.79 112.4
Year Range
94.35 177.97
Want to track BLDR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 75 days
Why the Market Dipped But Builders FirstSource (BLDR) Gained Today

Why the Market Dipped But Builders FirstSource (BLDR) Gained Today

Builders FirstSource (BLDR) concluded the recent trading session at $194.52, signifying a +0.32% move from its prior day's close.

Zacks | 1 year ago
Builders FirstSource, Inc. (BLDR) Is a Trending Stock: Facts to Know Before Betting on It

Builders FirstSource, Inc. (BLDR) Is a Trending Stock: Facts to Know Before Betting on It

Builders FirstSource (BLDR) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks | 1 year ago
Investors Heavily Search Builders FirstSource, Inc. (BLDR): Here is What You Need to Know

Investors Heavily Search Builders FirstSource, Inc. (BLDR): Here is What You Need to Know

Zacks.com users have recently been watching Builders FirstSource (BLDR) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks | 1 year ago
Why Is Builders FirstSource (BLDR) Up 10.5% Since Last Earnings Report?

Why Is Builders FirstSource (BLDR) Up 10.5% Since Last Earnings Report?

Builders FirstSource (BLDR) reported earnings 30 days ago. What's next for the stock?

Zacks | 1 year ago
These 2 Sectors Could Provide Roadmap for the Market

These 2 Sectors Could Provide Roadmap for the Market

When trying to figure out where the economy is going (let alone the stock market), investors often throw a handful or three indicators to keep track of without knowing which is accurate and which is not. So, to keep all the noise out, investors can trust the data tested by one of Wall Street's best investors, Stanley Druckenmiller.

Marketbeat | 1 year ago
These 2 Sectors Could Proivde Roadmap for the Market

These 2 Sectors Could Proivde Roadmap for the Market

When trying to figure out where the economy is going (let alone the stock market), investors often throw a handful or three indicators to keep track of without knowing which is accurate and which is not. So, to keep all the noise out, investors can trust the data tested by one of Wall Street's best investors, Stanley Druckenmiller.

Marketbeat | 1 year ago
Stock of the Day: Do Overbought Conditions Mean Builders FirstSource Is About To Reverse?

Stock of the Day: Do Overbought Conditions Mean Builders FirstSource Is About To Reverse?

Momentum refers to how far a stock's price has moved in a given time. For the most part, stocks stay within their average or typical range.

Benzinga | 1 year ago
Here is What to Know Beyond Why Builders FirstSource, Inc. (BLDR) is a Trending Stock

Here is What to Know Beyond Why Builders FirstSource, Inc. (BLDR) is a Trending Stock

Recently, Zacks.com users have been paying close attention to Builders FirstSource (BLDR). This makes it worthwhile to examine what the stock has in store.

Zacks | 1 year ago
S&P 500 Gains and Losses Today: Rate-Sensitive Stocks Jump After Powell's Remarks

S&P 500 Gains and Losses Today: Rate-Sensitive Stocks Jump After Powell's Remarks

Major U.S. equities indexes climbed in the week's final trading session as Federal Reserve Chair Jerome Powell reinforced expectations that lower interest rates are on the horizon.

Investopedia | 1 year ago
Cingulate stock surges 115% after European patent approval for ADHD treatment: Is it a buy?

Cingulate stock surges 115% after European patent approval for ADHD treatment: Is it a buy?

Cingulate Inc (NASDAQ: CING), a biopharmaceutical firm specializing in innovative ADHD treatments, experienced a remarkable surge in its stock price on Friday, with shares skyrocketing by 115%. This dramatic increase is attributed to the company's recent achievement of securing a European patent for CTx-1301, its flagship ADHD treatment.

Invezz | 1 year ago
Is Trending Stock Builders FirstSource, Inc. (BLDR) a Buy Now?

Is Trending Stock Builders FirstSource, Inc. (BLDR) a Buy Now?

Builders FirstSource (BLDR) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks | 1 year ago
Builders FirstSource's (BLDR) Shares Dip on Q2 Earnings Miss

Builders FirstSource's (BLDR) Shares Dip on Q2 Earnings Miss

Builders FirstSource's (BLDR) second-quarter results witness weaker Single-Family and Multi-Family markets.

Zacks | 1 year ago
Loading...
Load More